StockData

Cannabis Bioscience International Holdings, Inc. (CBIH) stock

CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026Score 0/30
$0.00+0.00 (+33.33%)

Close on Oct 19, 2026Market cap $2.33MP/E –Yield –

Cannabis Bioscience International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cannabis Bioscience International's revenue for the twelve months ending Feb 28, 2026 was $123.63K, down 64.1% year over year. For fiscal 2025 it was $303.02K, up 21.8% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025May 31, 2025$303.02K+21.8%
FY2024May 31, 2024$248.84K-21.5%
FY2023May 31, 2023$316.83K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Feb 28, 2026$11.21K-25.0%
Q2 FY2026CQ4 2025Nov 30, 2025$53.27K-28.3%
Q1 FY2026CQ3 2025Aug 31, 2025$24.20K-86.5%
Q4 FY2025CQ2 2025May 31, 2025$34.96K-53.9%
Q3 FY2025CQ1 2025Feb 28, 2025$14.93K-59.0%
Q2 FY2025CQ4 2024Nov 30, 2024$74.25K+16.5%
Q1 FY2025CQ3 2024Aug 31, 2024$178.89K+145.7%
Q4 FY2024CQ2 2024May 31, 2024$75.86K+63.5%
Q3 FY2024CQ1 2024Feb 29, 2024$36.41K-29.0%
Q2 FY2024CQ4 2023Nov 30, 2023$63.75K-22.8%
Q1 FY2024CQ3 2023Aug 31, 2023$72.82K–
Q4 FY2023CQ2 2023May 31, 2023$46.41K–
Q3 FY2023CQ1 2023Feb 28, 2023$51.25K–
Q2 FY2023CQ4 2022Nov 30, 2022$82.58K–

More Cannabis Bioscience International figures

See a number that looks wrong?